Marvel Presenting at the 2025 Bloom Burton & Co. Conference
Detailed price information for Marvel Biosciences Corp (MRVL-X) from The Globe and Mail including charting and trades.
The Globe and Mail11d
Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc ...